# PRD: AI Clinical Trial Management System
> **DISCLAIMER:** All data in this document is synthetic/mock. Meridian Health Sciences is a fictional organization. All trial data, patient counts, and clinical figures are fabricated for demonstration purposes.

## Executive Summary
Meridian Health Sciences (fictional) seeks an AI-powered clinical trial management system to reduce visit-window violations by 80%, enable real-time adverse-event signal detection, and automate CDISC SDTM/ADaM dataset generation for FDA submissions. The platform integrates HL7 FHIR for EHR interoperability and complies with FDA 21 CFR Part 11.

## Problem Statement
Meridian currently manages 23 active trials across 187 global sites. Coordinators manually track 4,200 subject visits/month, resulting in a 22% visit-window violation rate. Safety signals from adverse events are reviewed in monthly aggregate reports, creating a 30-day detection lag. CDISC dataset preparation requires 6 weeks of manual mapping per study with a 14% post-mapping query rate from the FDA.

## Goals & Non-Goals
### Goals
- Reduce visit-window violations from 22% to <5% via automated scheduling and reminders
- Enable real-time (within 4 hours) adverse-event signal detection using NLP on narrative AE reports
- Automate 90% of SDTM/ADaM dataset generation, reducing preparation time from 6 weeks to 5 days
- Achieve FDA 21 CFR Part 11 compliance for all electronic records and signatures

### Non-Goals
- Replacing electronic data capture (EDC) systems (integration, not replacement)
- Supporting pre-clinical or animal study workflows
- Providing direct patient-facing interfaces (clinician-only in v1.0)

## User Stories
### Clinical Research Coordinator
**As a** Clinical Research Coordinator,
**I want to** manage 15+ concurrent trial sites with automated visit scheduling,
**So that** I can improve patient safety and accelerate study timelines.

**Acceptance Criteria:**
- System enforces protocol-defined visit windows with automated alerts
- All data transformations produce CDISC-compliant output validated by Pinnacle 21
- Complete audit trail meets 21 CFR Part 11 requirements

### Principal Investigator
**As a** Principal Investigator,
**I want to** real-time safety signal detection across all enrolled subjects,
**So that** I can improve patient safety and accelerate study timelines.

**Acceptance Criteria:**
- System enforces protocol-defined visit windows with automated alerts
- All data transformations produce CDISC-compliant output validated by Pinnacle 21
- Complete audit trail meets 21 CFR Part 11 requirements

### Data Manager
**As a** Data Manager,
**I want to** automated cdisc-compliant data transforms for fda submission,
**So that** I can improve patient safety and accelerate study timelines.

**Acceptance Criteria:**
- System enforces protocol-defined visit windows with automated alerts
- All data transformations produce CDISC-compliant output validated by Pinnacle 21
- Complete audit trail meets 21 CFR Part 11 requirements

## Technical Architecture
- **EHR Integration:** HL7 FHIR R4 APIs connecting to Epic, Cerner, and Medidata Rave via SMART on FHIR
- **Safety Signal Engine:** NLP pipeline (BioBERT) processing narrative AE reports; statistical disproportionality analysis (PRR, EBGM)
- **CDISC Automation:** Rule-based + ML mapping engine converting raw CRF data to SDTM/ADaM with Pinnacle 21 validation
- **Storage:** HIPAA-compliant PostgreSQL with TDE; audit logs in append-only TimescaleDB
- **Compute:** HIPAA-eligible AWS (GovCloud) with dedicated VPC, KMS encryption, and BAA coverage
- **API Layer:** RESTful APIs with mutual TLS, OAuth 2.0 + SMART scopes, and RBAC per study/site

## Success Metrics
| Metric | Baseline | Target | Timeframe |
|---|---|---|---|
| Visit-window violations | 22% | <5% | 6 months |
| AE signal detection lag | 30 days | 4 hours | 4 months |
| SDTM prep time per study | 6 weeks | 5 days | 8 months |
| FDA query rate on datasets | 14% | <3% | 8 months |

## Risks & Mitigations
| Risk | Likelihood | Impact | Mitigation |
|---|---|---|---|
| EHR FHIR endpoint downtime | Medium | High | Offline queue with retry + manual fallback workflow |
| NLP misclassifies serious AE as non-serious | Low | Critical | Dual-review: AI flags + mandatory clinician confirmation |
| 21 CFR Part 11 audit finding | Medium | Critical | Pre-launch mock FDA audit + quarterly compliance reviews |
| CDISC standard version update mid-study | Low | Medium | Version-pinned mapping configs + migration tooling |

## Timeline
| Phase | Duration | Deliverables |
|---|---|---|
| Discovery & Compliance Mapping | Weeks 1-6 | 21 CFR gap analysis, FHIR integration specs, UX prototypes |
| MVP (Visit Scheduling + FHIR) | Weeks 7-18 | Automated scheduling, EHR connectivity, basic AE capture |
| Beta (Safety Signals + CDISC) | Weeks 19-30 | NLP safety engine, SDTM automation, Pinnacle 21 validation |
| GA + FDA Submission Support | Weeks 31-38 | Full platform, submission-ready datasets, SOPs, training |

## Open Questions
1. Will Meridian require GxP-validated cloud infrastructure or accept qualified infrastructure?
2. Should the NLP safety engine support languages beyond English for global trial sites?
3. What EDC systems beyond Medidata Rave require integration in v1.0?
